# Cyabra, Inc.: overview
CYAB · Nasdaq · CIK 2032341 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31
Pages: [Overview](/companies/cyab.md) · [Financials](/companies/cyab/financials.md) · [Filings](/companies/cyab/filings.md) · [Insiders](/companies/cyab/insiders.md)
Latest reported revenue: [$1.9m](/filings/0001213900-26-088752.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-088752).
## Last eight quarters
| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,260](/filings/0001213900-26-057819.md) | [1,331](/filings/0001213900-26-088752.md) | [1,415](/filings/0001213900-26-057819.md) | [1,853](/filings/0001213900-26-088752.md) |
| Gross margin | % | [84.4%](/filings/0001213900-26-057819.md) | [84.0%](/filings/0001213900-26-088752.md) | [86.4%](/filings/0001213900-26-057819.md) | [83.6%](/filings/0001213900-26-088752.md) |
| Operating margin | % | [(320.5%)](/filings/0001213900-26-057819.md) | [(256.9%)](/filings/0001213900-26-088752.md) | [(835.6%)](/filings/0001213900-26-057819.md) | [(168.4%)](/filings/0001213900-26-088752.md) |
| Net margin | % | [(263.0%)](/filings/0001213900-26-057819.md) | [(183.8%)](/filings/0001213900-26-088752.md) | [(761.1%)](/filings/0001213900-26-057819.md) | [(185.6%)](/filings/0001213900-26-088752.md) |
| Diluted EPS | $ per share | [(1.47)](/filings/0001213900-26-057819.md) | [(1.07)](/filings/0001213900-26-088752.md) | [(3.10)](/filings/0001213900-26-057819.md) | [(0.26)](/filings/0001213900-26-088752.md) |
| Free cash flow | $k | [(1,285)](/filings/0001213900-26-057819.md) | [(2,577) d](/filings/0001213900-26-088752.md) | [(2,603)](/filings/0001213900-26-057819.md) | [(2,420) d](/filings/0001213900-26-088752.md) |
- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure.
## Last five fiscal years
| Line item | Unit | FY2025 (2025-12-31) |
| --- | --- | ---: |
| Revenue | $ | not reported |
| Gross margin | % | not reported |
| Operating margin | % | not reported |
| Net margin | % | not reported |
| Diluted EPS | $ per share | [(156.35)](/filings/0001213900-26-034218.md) |
| Free cash flow | $ | not reported |
- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL not reported.
Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.
## Insider purchases and sales
The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cyab/insiders.md)
None in coverage.
## Funds that report holding it
From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $52.0k | 132,755 | | New +132,755 |
| [Shay Capital LLC](/funds/1723643.md) | 2026-06-30 | $46.2k | 117,877 | | Added +65,006 |
| [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $41.5k | 68,028 | | New +68,028 |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $33.0k | 84,228 | | New +84,228 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $10.7k | 27,321 | | New +27,321 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $8.0k | 20,362 | | New +20,362 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $7.8k | 19,858 | | New +19,858 |
| [Limestone Investment Advisors LP](/funds/2075597.md) | 2026-06-30 | $6.7k | 17,000 | | Unchanged |
| [McGuire Investment Group, LLC](/funds/1756959.md) | 2026-06-30 | $5.8k | 14,705 | | New +14,705 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $745 | 1,902 | | Added +1,874 |
## Recent filings
[All 85 filings](/companies/cyab/filings.md)
| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 14:09 ET | [DEF 14A](/filings/0001213900-26-110049.md) | Proxy statement, period 2026-11-10 | 0001213900-26-110049 |
| 2026-10-08 | 01:36 ET | [S-1](/filings/0001213900-26-107694.md) | Registration statement | 0001213900-26-107694 |
| 2026-09-16 | 00:28 ET | [S-1/A](/filings/0001213900-26-100260.md) | Registration statement, amended | 0001213900-26-100260 |
| 2026-09-10 | 10:05 ET | [8-K](/filings/0001213900-26-098557.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-098557 |
| 2026-09-03 | 13:10 ET | [8-K](/filings/0001213900-26-096962.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-096962 |
| 2026-09-01 | 21:21 ET | [S-1/A](/filings/0001213900-26-096300.md) | Registration statement, amended | 0001213900-26-096300 |
| 2026-08-13 | 13:00 ET | [10-Q](/filings/0001213900-26-088752.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088752 |
| 2026-08-11 | 21:32 ET | [DEF 14A](/filings/0001213900-26-087367.md) | Proxy statement, period 2026-09-02 | 0001213900-26-087367 |
| 2026-07-31 | 20:01 ET | [8-K](/filings/0001213900-26-083952.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-083952 |
| 2026-07-31 | 23:10 ET | [S-1](/filings/0001213900-26-083475.md) | Registration statement | 0001213900-26-083475 |
## Latest annual report
[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-034218.md), filed Mar 26, 2026.
## Forecast league
Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a3b7bf05-e262-43f0-b32e-a03826c11fa6)
## About the filer
- CIK: 2032341
- Tickers: CYAB
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.